Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting

2003 ◽  
Vol 12 (5) ◽  
pp. 56
Author(s):  
A. Dibra ◽  
J. Mehilli ◽  
S. Braun
Keyword(s):  
Coronary Artery ◽  
Stable Angina ◽  
C Reactive Protein ◽  
Cardiac Events ◽  
Protein Levels ◽  
Reactive Protein ◽  
Coronary Artery Stenting

Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina

1998 ◽  
Vol 82 (4) ◽  
pp. 515-518 ◽  
Author(s):  
Achille Gaspardone ◽  
Filippo Crea ◽  
Francesco Versaci ◽  
Fabrizio Tomai ◽  
Antonio Pellegrino ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Stable Angina ◽  
Predictive Value ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Coronary Artery Stenting

Complement C3 and C-reactive protein levels in patients with stable coronary artery disease

2005 ◽  
Vol 94 (11) ◽  
pp. 1048-1053 ◽  
Author(s):  
Ramzi Ajjan ◽  
Timothy Futers ◽  
Jane Brown ◽  
Charlotte Cymbalista ◽  
May Boothby ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Fasting Glucose ◽  
Stable Coronary Artery Disease ◽  
Complement C3 ◽  
C Reactive Protein ◽  
Protein Levels ◽  
Reactive Protein ◽  
The Metabolic Syndrome ◽  
Artery Disease

SummaryThe aim of this study was to determine whether complement C3 is an indicator of coronary artery disease (CAD). We measured plasma C3 and CRP levels in 278 patients undergoing coronary angiography for typical symptoms of CAD and 269 healthy age and sex matched controls. C3 levels were significantly higher in patients compared with controls (1.15 g/l and 0.92 g/l respectively; p<0.001). In the patient group, C3 levels correlated with BMI, fasting glucose, HbA1c, fibrinogen, CRP and HDL in both men and women. CRP levels were also higher in patients compared with controls (1.14 mg/l and 0.86 mg/l respectively; p=0.005) and correlated with markers of the metabolic syndrome. In a logistic regression model including C3, smoking, hypertension, cholesterol and diabetes, C3 was independently associated with CAD with an odds ratio of 3.20 for a 1 SD increase in C3 levels. In contrast, CRP was not independently associated with CAD in a similar regression analysis. In conclusion, both C3 and CRP plasma levels are elevated in patients with symptoms of CAD. However, C3 seems to be a better indicator of CAD than CRP in this study, suggesting that C3 could be an additional marker for risk stratification in atherosclerosis.

scholarly journals Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease

2005 ◽  
Vol 26 (20) ◽  
pp. 2099-2105 ◽  
Author(s):  
Fabrizio Tomai ◽  
Flavio Ribichini ◽  
Anna S. Ghini ◽  
Valeria Ferrero ◽  
Giuseppe Andò ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Microvascular Dysfunction ◽  
Coronary Microvascular Dysfunction ◽  
C Reactive Protein ◽  
Protein Levels ◽  
Reactive Protein ◽  
Artery Disease

scholarly journals Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study

2014 ◽  
Vol 15 (1) ◽  
Author(s):  
Maria Udeanu ◽  
Giordano Guizzardi ◽  
Giuseppe Di Pasquale ◽  
Antonio Marchetti ◽  
Francesca Romani ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Retrospective Study ◽  
Coronary Artery ◽  
Renal Dysfunction ◽  
C Reactive Protein ◽  
Protein Levels ◽  
Reactive Protein ◽  
Artery Disease
Sign in / Sign up

Export Citation Format

Share Document